These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7942881)

  • 1. Drop size of ocular carteolol hydrochloride.
    Sorensen SJ; Abel SR
    Am J Hosp Pharm; 1994 Jun; 51(11):1470, 1473. PubMed ID: 7942881
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
    Ishii Y; Nakamura K; Matsuki S; Uemura N; Muraguchi R; Nakagawa M; Nakano S; Nakatsuka K
    J Clin Pharmacol; 2002 Sep; 42(9):1020-6. PubMed ID: 12211218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride.
    El-Kamel A; Al-Dosari H; Al-Jenoobi F
    Drug Deliv; 2006; 13(1):55-9. PubMed ID: 16401594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible treatment of migraine with carteolol hydrochloride.
    Shapiro MK; Gorn R
    Headache; 1999 Feb; 39(2):138-9. PubMed ID: 18567128
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
    J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level.
    Safran AB; Simona F; Sansonetti A; Pometta D; James R
    Am J Ophthalmol; 1994 May; 117(5):683. PubMed ID: 8172288
    [No Abstract]   [Full Text] [Related]  

  • 9. [The deleterious effect of certain surface active agents on the ocular surface].
    Ravet O
    Bull Soc Belge Ophtalmol; 2007; (304):145-9. PubMed ID: 17718239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical beta blockers and atrioventricular block in the elderly.
    Ruiz-Ruiz FJ; Perez-Calvo JI; Sanjuan-Cuartero R
    J Postgrad Med; 2002; 48(4):327-8. PubMed ID: 12571398
    [No Abstract]   [Full Text] [Related]  

  • 11. First report of sweating associated with topical beta-blocker therapy.
    Schmutz JL; Barbaud A; Reichert S; Vasse JP; Trechot P
    Dermatology; 1997; 194(2):197-8. PubMed ID: 9094480
    [No Abstract]   [Full Text] [Related]  

  • 12. [Case from general practice. Bradycardic atrial flutter].
    Osterwalder P; Garzoli G; Greminger P
    Praxis (Bern 1994); 1998 Aug; 87(33):1034-6. PubMed ID: 9747135
    [No Abstract]   [Full Text] [Related]  

  • 13. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of eye drop size.
    Van Santvliet L; Ludwig A
    Surv Ophthalmol; 2004; 49(2):197-213. PubMed ID: 14998692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic interactions among haloperidol, carteolol hydrochloride and biperiden hydrochloride.
    Isawa S; Murasaki M; Miura S; Yoshioka M; Uchiumi M; Kumagai Y; Aoki S; Hisazumi H; Kudo S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Jul; 19(3):111-8. PubMed ID: 10495985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research and correlation analysis on the dripper contamination of carteolol hydrochloride eye drops.
    Wang YM; Ren YL; Xu J; Zhang XF
    Ann Palliat Med; 2021 Jun; 10(6):6779-6785. PubMed ID: 34154346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye drop container delivery: a source of response variation?
    German EJ; Hurst MA; Wood D
    Ophthalmic Physiol Opt; 1997 May; 17(3):196-204. PubMed ID: 9196661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage variability of topical ocular hypotensive products: a densitometric assessment.
    Gaynes BI; Singa RM; Cao Y
    J Glaucoma; 2009 Feb; 18(2):149-52. PubMed ID: 19225353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new eye drop package.
    Christensen K; Garup K
    Am J Hosp Pharm; 1968 Sep; 25(9):524-7. PubMed ID: 5671561
    [No Abstract]   [Full Text] [Related]  

  • 20. [The evaluation of compressibility of plastic eye-drop bottles].
    Beyrich T
    Pharmazie; 1976 Aug; 31(8):577. PubMed ID: 996083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.